Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
US7097840 | NA | Methods of treatment using anti-ErbB antibody-maytansinoid conjugates |
Jul, 2026
(2 years from now) |
Ingredients: ADO-TRASTUZUMAB
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic